- Home
- CPA vs AXSM Comparison
CPA vs AXSM Comparison
Compare CPA & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CPA
- AXSM
- Stock Information
- Founded
- CPA 1947
- AXSM 2012
- Country
- CPA Panama
- AXSM United States
- Employees
- CPA N/A
- AXSM N/A
- Industry
- CPA Air Freight/Delivery Services
- AXSM Biotechnology: Pharmaceutical Preparations
- Sector
- CPA Consumer Discretionary
- AXSM Health Care
- Exchange
- CPA Nasdaq
- AXSM Nasdaq
- Market Cap
- CPA 3.6B
- AXSM 4.2B
- IPO Year
- CPA 2005
- AXSM 2015
- Fundamental
- Price
- CPA $91.78
- AXSM $84.60
- Analyst Decision
- CPA Strong Buy
- AXSM Strong Buy
- Analyst Count
- CPA 7
- AXSM 14
- Target Price
- CPA $156.14
- AXSM $125.54
- AVG Volume (30 Days)
- CPA 296.5K
- AXSM 893.5K
- Earning Date
- CPA 02-05-2025
- AXSM 02-18-2025
- Dividend Yield
- CPA 7.06%
- AXSM N/A
- EPS Growth
- CPA 62.61
- AXSM N/A
- EPS
- CPA 15.07
- AXSM N/A
- Revenue
- CPA $3,480,417,000.00
- AXSM $338,457,000.00
- Revenue This Year
- CPA $0.72
- AXSM $44.77
- Revenue Next Year
- CPA $6.95
- AXSM $67.70
- P/E Ratio
- CPA $5.85
- AXSM N/A
- Revenue Growth
- CPA 1.33
- AXSM 51.47
- 52 Week Low
- CPA $80.01
- AXSM $64.11
- 52 Week High
- CPA $114.00
- AXSM $105.00
- Technical
- Relative Strength Index (RSI)
- CPA 56.15
- AXSM 43.66
- Support Level
- CPA $85.27
- AXSM $79.19
- Resistance Level
- CPA $90.64
- AXSM $87.53
- Average True Range (ATR)
- CPA 2.31
- AXSM 4.37
- MACD
- CPA 0.63
- AXSM -0.02
- Stochastic Oscillator
- CPA 98.70
- AXSM 61.27
About CPA Copa Holdings S.A.
Copa Holdings SA is a provider of airline passenger and cargo services through its subsidiaries. The company operates through the air transportation segment. It offers international air transportation for passengers, cargo, and mail, operating from its Panama City hub in the Republic of Panama and domestic and international air transportation for passengers, cargo and mail with a point-to-point route network through Copa Colombia a Colombian air carrier. The company's geographical segments are North America, South America, Central America, and the Caribbean. It derives the maximum revenue from North America.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.